Trial intelligence / Profile preview

Minidex very low-dose dexamethasone trial in ventilator-dependent preterm infants at high risk of bronchopulmonary dysplasia

ISRCTN81191607Phase 2Completed

Sponsor
University of Liverpool
Start
Nov 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of dexamethasone in bronchopulmonary dysplasia (BPD), sponsored by University of Liverpool. Started Nov 2016; status: completed.

02

Drugs

dexamethasone
03

Conditions

bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on ISRCTN81191607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN81191607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call